Nanopatch creates a more accessible vaccine

After 160 years of administering vaccines using needles, biomedical engineer, Mark Kendall, believes the future of vaccination literally lies beneath a finger sized patch the size of your finger tip. The patch is covered in tiny spikes, and rather than a large needle injection to the muscle, the spikes deliver the medication just beneath the skin.

The nanopatch is designed to place a tiny amount of vaccine just under the skin without the need for a needle jab. Because it delivers the active ingredient right to where it is needed, tests have shown it can generate same immune response with only a fraction of the dose needed in a conventional vaccine. The vaccine could be especially benefical for those living in poorer, tropical, remote countries - need something simpler, stabler and easier to use. 

Could a tiny patch help decrease the number of outbreaks each year, especially influenza? And will self injection/self administering change the world of vaccination?

At the 17th annual Drug Delivery Partnerships we'll cover the evolution of discovery and delivery. Dr. Geoffrey Hird, Principal Scientist, Formulation & Drug Delivery Technologies, EISAI and Ping Yeh, Executive Director,Product and Process Development, AMGEN lead our Session: Connect Discovery with Development – Reinvent the Industry and Be More Efficient. To find out more about our event, download the brochure.

As a reader of the Drug Delivery Partnerships blog, you get a 15% discount off the standard rate when using code XP1878BLOG to register. We look forward to seeing you February 6-8 in San Diego, CA!